Cuba conducts phase III clinical trial for ataxia type two d

Havana, Jan 31 (Prensa Latina) A phase III clinical trial to evaluate the efficacy and safety of the nasal administration of NeuroEPO in adult patients with spinocerebellar ataxias is being successfully developed in Cuba.

Related Keywords

Cuba , Cuban , Ataxias Cirah , Manuel Marrero , Cuban Academy Of Sciences , Science Luis Vel , Hereditary Ataxias , Cuban Academy , Molecular Immunology , Prime Minister ,